# EDGAR Filing Document

**Accession Number:** 0002104168
**File Stem:** 9999999995-26-000429
**Filing Date:** 2026-1
**Character Count:** 1267
**Document Hash:** 379554f2e93d222eec765a2d846a26ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-000429.hdr.sgml**: 20260202

**ACCESSION NUMBER**: 9999999995-26-000429

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260130

**DATE AS OF CHANGE**: 20260202

**EFFECTIVENESS DATE**: 20260130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AGOMAB THERAPEUTICS NV/ADR
- **CENTRAL INDEX KEY:** 0002104168
- **ORGANIZATION NAME:** International Corp Fin
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C9
- **FISCAL YEAR END:** 1226

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292962
- **FILM NUMBER:** 26585537

**BUSINESS ADDRESS:**
- **STREET 1:** 120 BROADWAY, 32ND FLOOR
- **STREET 2:** 32ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10271
- **BUSINESS PHONE:** 212-238-3221

**MAIL ADDRESS:**
- **STREET 1:** 120 BROADWAY, 32ND FLOOR
- **STREET 2:** 32ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10271

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** January 30, 2026

**Time:** 16:01:00

**Form Type:** F-6

---

**CIK:** 0002104168

**Company Name:** AGOMAB THERAPEUTICS NV/ADR

**File Number:** 333-292962